The Role of the Urokinase Receptor in Epilepsy, in Disorders of Language, Cognition, Communication and Behavior, and in the Central Nervous System

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|19|1914-1923

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.19, 2011-06, pp. : 1914-1923

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Urokinase Receptor in the Central Nervous System

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 2, 2011-03 ,pp. : 271-294

Bentham Science Publishers

Access to resources Recommend Favorite

Histamine H3 Receptor: A Potential Drug Target for the Treatment of Central Nervous System Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-01 ,pp. : 303-313

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Flavonoids in Central Nervous System Disorders

By  

Current Medicinal Chemistry, Vol. 20, Iss. 37, 2013-11 ,pp. : 4694-4719

Bentham Science Publishers

Access to resources Recommend Favorite

Autophagy in the Central Nervous System: Implications for Neurodegenerative Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 701-719

Bentham Science Publishers

Access to resources Recommend Favorite

New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 10, Iss. 2, 2010-06 ,pp. : 148-157

Bentham Science Publishers

Access to resources Recommend Favorite